孔圣枕中丹化裁方对肾虚痰瘀型脑小血管病患者认知功能、炎症因子及中医证候积分的影响OA
Effects of Modified Kongsheng Zhenzhong Pill on Cognitive Function,Inflammatory Factors,and Traditional Chinese Medicine Syndrome Scores in Patients with Cerebral Small Vessel Disease of Kidney Deficiency and Phlegm-Stasis Type
目的:探讨孔圣枕中丹化裁方对肾虚痰瘀型脑小血管病(CSVD)患者认知功能、炎症因子及中医证候积分的影响.方法:回顾性选取西安市中医医院脑病科 2020 年 1 月—2025 年 1 月 CSVD(肾虚痰瘀型)住院患者210 例,其中接受常规治疗的104 例患者纳入基础组,在常规治疗基础上接受孔圣枕中丹化裁方治疗的106 例患者纳入研究组,对比两组临床疗效、认知功能[蒙特利尔量表(MoCA)与简易精神状态评价量表(MMSE)]、炎症因子[超敏 C 反应蛋白(hs-CRP)、白细胞介素(IL)-1β、IL-6]及中医证候积分.结果:研究组总有效率高于基础组,差异有统计学意义(P<0.05).两组治疗前认知功能各项评分比较,差异无统计学意义(P>0.05),研究组患者治疗后 MoCA 评分及 MMSE 评分均高于基础组(P<0.01).两组治疗前炎症因子比较,差异无统计学意义(P>0.05),研究组治疗后 hs-CRP、IL-1β及 IL-6 水平均低于基础组(P<0.01).两组治疗前中医证候各项积分比较,差异无统计学意义(P>0.05);研究组治疗后智能减退、咯痰、纳呆脘胀、大便黏腻等证候积分均低于基础组(P<0.01).结论:针对 CSVD(肾虚痰瘀型)患者应用孔圣枕中丹化裁方,可获得显著疗效,促使患者认知功能及中医证候改善,降低其炎症因子水平,疗效优于单纯常规治疗.
Objective:To investigate the effects of Kongsheng Zhenzhong Pill Modified Formula on cognitive function,inflammatory factor and Chinese medicine syndrome score in patients with cerebral small vessel disease(CSVD)with kidney deficiency,phlegm and stasis type.Methods:A retrospective selection was made of 210 inpatients with CSVD(kidney deficiency and phlegm-stasis type)from the Department of Neurology of Xi'an Hospital of Traditional Chinese Medicine from January 2020 to January 2025,among which 104 patients receiving conventional treatment were included in the basic group and 106 patients who received the modified formula of Kongsheng Zhenzhong Pill Modified Formula on the basis of conventional treatment were included in the study group,and the efficacy of the 2 groups,cognitive function[Montreal Scale(MoCA)and the Simple Mental State Evaluation(MMSE)scale],inflammatory factors(Hypercalcitrance and inflammation factor),and inflammatory factors(Hypercalcitrance and inflammation factor)were compared with those in the other group,inflammatory factors[Hypersensitive C-reactive protein(hs-CRP),interleukin(IL)-1β,IL-6]and TCM evidence score.Results:Among the 210 patients with CSVD(kidney deficiency and phlegm-stasis type)in this study,106 cases were included in the study group and 104 cases in the control group.The total effective rate of the study group was higher than that of the basic group,and the difference was statistically significant(P<0.05).Comparison of various scores of cognitive function before treatment between the two groups showed no significant difference(P>0.05),and the MoCA score and MMSE score of patients in the study group were higher than those in the basic group after treatment(P<0.05).Comparison of inflammatory factors before treatment between the two groups,there was no significant difference(P>0.05),and the levels of hs-CRP,IL-1β and IL-6 were lower than those of the basic group after treatment in the study group(P<0.05).There was no significant difference between the two groups when comparing the points of Chinese medicine symptoms before treatment(P>0.05),and the points of symptoms such as diminished intelligence,phlegm,nausea and epigastric distension,and sticky stools were lower than those of the basic group after the treatment in the research group(P<0.05).Conclusion:The application of Kongsheng Zhenzhong Pill Modified Formula for CSVD(kidney deficiency,phlegm and stasis type)patients can achieve significant therapeutic effects,improve cognitive function and Chinese medicine symptoms,and reduce the level of inflammatory factors in the patients.The therapeutic effect is superior to that of conventional treatment alone.
宋高伟;张强强;王琢;杨林肖;杨思清;杨琳
陕西中医药大学,陕西 咸阳 712046西安市中医医院,陕西 西安 710021陕西中医药大学,陕西 咸阳 712046西安市中医医院,陕西 西安 710021西安市中医医院,陕西 西安 710021西安市中医医院,陕西 西安 710021
医药卫生
孔圣枕中丹化裁方脑小血管病肾虚痰瘀型认知功能炎症因子
Kongsheng Zhenzhong Pill Modified FormulaCerebral small vessel diseaseRenal deficiency,Phlegm stasis typeCognitive functionInflammatory factor
《中医药学报》 2026 (5)
82-86,5
西安市卫生健康委项目(2025ms02)
评论